| Literature DB >> 35081158 |
Safia Sharif1, Suzanne Fergus1, Amira Guirguis1,2, Nigel Smeeton3, Fabrizio Schifano1.
Abstract
BACKGROUND: Cognitive enhancers (CE) are often used to improve memory, alertness and cognitive capacity. These products are commercially and pharmaceutically available. Due to high academic pressure, university students are at risk of CE misuse. However, data regarding this issue are limited, especially in the United Arab Emirates (UAE). AIMS: To assess the prevalence of CE intake; evaluate students' knowledge of these substances; and identify student characteristics associated with CE usage.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35081158 PMCID: PMC8791475 DOI: 10.1371/journal.pone.0262704
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic characteristics of respondents from the UAE Universities.
| Number | 522 | |
|---|---|---|
|
| Female | 307 (59.5%) |
| Male | 209 (40.5%) | |
| (Missing) | 6 | |
|
| 18–25 years | 494 (94.6%) |
| 26–35 years | 15 (2.9%) | |
| above 35 | 13 (2.5%) | |
|
| No | 390 (74.7%) |
| Yes | 132 (25.3%) | |
|
| UK | 14 (5.8%) |
| EU | 1 (0.4%) | |
| USA | 2 (0.8%) | |
| UAE | 69 (28.8%) | |
| Arab countries | 73 (30.4%) | |
| Asian countries | 62 (25.8%) | |
| Other | 19 (7.9%) | |
| (Missing) | 282 | |
|
| Medicine | 104 (51.2%) |
| Pharmacy | 38 (18.7%) | |
| Dentistry | 33 (16.3%) | |
| Nursing | 9 (4.4%) | |
| Engineering | 19 (9.4%) | |
| (Missing) | 319 | |
|
| First | 37 (15.7%) |
| Second | 40 (17.0%) | |
| Third | 67 (28.4%) | |
| Fourth | 71 (30.1%) | |
| Fifth | 19 (8.1%) | |
| Sixth | 2 (0.9%) | |
| (Missing) | 286 |
Data are presented as frequencies (percentage of the non-missing responses from the UAE universities), missing values are shown for comprehensive reporting purpose only. Percentages may not sum to 100 due to rounding.
UAE students; demographics of CEs users vs non-users.
| Number | users 132 | non-users 390 | p value | |
|---|---|---|---|---|
|
| Female | 40 (30.5%) | 267 (69.4%) | p<0.001 |
| Male (Missing) | 91 (69.5%) 1 | 118 (30.6%) 5 | ||
|
| 18–25 | 126 (95.5%) | 368 (94.4%) | p = 0.875 |
| 26–35 | 3 (2.3%) | 12 (3.1%) | ||
| above 35 | 3 (2.3%) | 10 (2.9%) |
* Significant difference between CE users and non-users.
UAE students; demographics of CEs users vs non-user reporters.
|
|
|
|
| |
| EU | 1 (0.8%) | 0 | ||
| USA | 1 (0.8%) | 1 (0.9%) | ||
| UAE | 55 (42%) | 14 (12.8%) | ||
| Arab countries | 49 (37.4%) | 24 (22%) | ||
| Asian countries | 16 (12.2%) | 46 (42.2%) | ||
| Other (Missing) | 1 (0.8%) 1 | 18 (16.5%) not applicable | ||
|
| Medicine | 64 (50%) | 36(50.7%) | p<0.001 |
| Pharmacy | 24 (18.8%) | 14 (19.7%) | ||
| Dentistry | 19 (14.8%) | 14 (19.7%) | ||
| Nursing | 2 (1.6%) | 7 (9.9%) | ||
| Engineering (Missing) | 19 (14.8%) 4 | 0 38 | ||
|
| First | 9 (6.9%) | 27 (26.7%) | p<0.001 |
| Second | 16 (12.1%) | 24 (23.8%) | ||
| Third | 39 (29.5%) | 27 (26.7%) | ||
| Fourth | 53 (40.2%) | 17 (16.8%) | ||
| Fifth | 12 (1.5%) | 6 (5.9%) | ||
| Sixth (Missing) | 2 (1.5%) 1 | 0 8 |
** Significant difference between CE users v. non-user reporters.
# Fisher’s exact test.
Percentages may not sum to 100 due to rounding.
Logistic regression analysis for CE use among university students in the UAE.
| Variables | Simple regression analysis | Multiple regression analysis | ||
|---|---|---|---|---|
| Crude ORa (95% CI) | p value | Adjusted ORb (95%CI) | p value | |
|
| ||||
|
| ||||
|
| 5.15 (3.35–7.92) | <0.001 | 6.91 (3.440–13.91) | <0.001 |
|
| ||||
|
| ||||
|
| 1.26 (0.50–3.20) | 0.630 | ||
|
| ||||
|
| ||||
|
| 1.19 (0.50–2.90) | 0.707 | 2.68 (0.95–7.51) | 0.062 |
|
| 0.16 (0.10–0.30) | 0.001 | 0.43 (0.17–1.08) | 0.073 |
|
| ||||
|
| ||||
|
| 0.988 (0.55–0.1.77) | 0.967 | ||
|
| ||||
|
| ||||
|
| 4.28 (2.39–7.69) | <0.001 | 2.40 (1.20–4.80) | 0.001 |
a: Simple logistic regression
b: Multiple logistic regression.
The model reasonably fits well, assumptions met and no interaction or multicollinearity problems.
Gender-based demographic distribution of CEs’ users among the UAE students.
| Female (40) | Male (91) | p value | ||
|---|---|---|---|---|
|
| 18–25 years | 36 (90%) | 89 (97.8%) | p = 0.053 |
| 26–35 years | 3 (7.5%) | 0 | ||
| above 35 years | 1 (2.5%) | 2 (2.2%) | ||
|
| Multiple CEs | 16 (43.2%) | 48 (53.3%) | p = 0.301 |
| Single CE | 21 (56.8%) | 42 (46.7%) | ||
|
| UK | 7 (17.5%) | 1 (1.1%) | p = 0.076 |
| EU | 0 | 1 (1.1%) | ||
| USA | 1 (1.1%) | 0 | ||
| UAE | 12 (30%) | 43 (47.3%) | ||
| Arabs | 13 (32.5%) | 35 (38.5%) | ||
| Asians | 6 (15%) | 10 (10.1%) | ||
| Other nationalities | 1 (2.5%) | 0 | ||
|
| Medicine | 17 (44.7%) | 47 (52.8%) | p = 0.012 |
| Pharmacy | 8 (21.1%) | 16 (18%) | ||
| Dentistry | 10 (26.3%) | 8 (9%) | ||
| Nursing | 2 (5.3%) | 0 | ||
| Engineering | 1 (2.6%) | 18 (20.2%) | ||
|
| First | 7 (17.5%) | 2 (2.2%) | p = 0.121 |
| Second | 7 (17.5%) | 9 (9.9%) | ||
| Third | 9 (22.5%) | 29 (31.9%) | ||
| Fourth | 15 (37.5%) | 38 (41.8%) | ||
| Fifth | 1 (2.5%) | 11 (12.1%) | ||
| Sixth | 1 (2.5%) | 1 (1.1%) |
*p values for chi-squared test (or #Fisher’s exact test where necessary) to compare the gender-based differences in the demographics among the CE users only.
Percentages may not sum to 100 due to rounding.
CE characteristics of use among UAE students; differences according to gender.
| Female(40) | Male (91) | p value | ||
|---|---|---|---|---|
|
| Concentration | 12(30.0%) | 24(26.4%) | 0.676 |
| Memory | 2 (5.0%) | 9 (9.9%) | 0.502 | |
| Alertness | 7(17.5%) | 26(28.6%) | 0.198 | |
| Academic performance | 9(22.5%) | 31(34.1%) | 0.220 | |
| Other reasons | 10 (25.0%) | 1 (1.1%) | <0.001 | |
|
| 24 (60.0%) | 80(87.9%) | 0.008 | |
|
| Exams | 27 (67.5%) | 78(85.7%) | 0.267 |
| Course deadlines | 2 (5.0%) | 1 (1.1%) | ||
| Studying | 5 (12.5%) | 9 (9.9%) | ||
| Daily | 4 (10.0%) | 1 (1.1%) | ||
| Other | 2 (5.0%) | 2 (2.2%) | ||
|
| < 1 month | 16 (40.0%) | 22(24.2%) | 0.027 |
| 1–6 months | 12 (30.0%) | 58(63.7%) | ||
| 6–12 months | 7 (17.5%) | 8 (8.8%) | ||
| 1–2 years | 0 | 2 (2.2%) | ||
| 2 years or more | 5 (12.5%) | 1 (1.1%) | ||
|
| Daily | 15 (37.5%) | 23(25.3%) | 0.705 |
| Weekly | 3 (7.5%) | 7 (7.7%) | ||
| Monthly | 3 (7.5%) | 8 (8.8%) | ||
| Once/semester | 9 (22.5%) | 34(37.4%) | ||
| < Once a semester | 8 (20.0%) | 18(19.8%) | ||
|
| Prescribed to me | 9 (22.5%) | 3 (3.3%) | 0.022 |
| Friend | 6 (15.0%) | 17(18.7%) | ||
| Online | 17 (42.5%) | 64(70.3%) | ||
| Other | 8 (20.0%) | 7 (7.7%) | ||
|
| Very expensive/ expensive | 12 (31.6%) | 56(62.9%) | 0.002 |
| Fair/Cheap | 26 (68.4%) | 33(37.1%) | ||
|
| Social media | 3 (7.5%) | 10 (11%) | 0.052 |
| Scientific literature | 3 (12.5%) | 2 (2.2%) | ||
| Internet | 9 (22.5%) | 24(26.4%) | ||
| Friends | 14 (35.0%) | 49(53.8%) | ||
| Family | 2 (5.0%) | 4 (4.4%) | ||
| Other | 7 (17.5%) | 2 (2.2%) | ||
|
| B12 | 18 (55.0%) | 32(35.2%) | 0.255 |
| B6# | 9 (22.5%) | 5 (5.5%) | 0.014 | |
| Methylphenidate | 3 (7.5%) | 9 (9.9%) | 0.864 | |
| Adderall/amphetamines# | 1 (2.5%) | 9 (9.9%) | 0.325 | |
| Super caffeine pills | 16 (40.0%) | 35(38.5%) | 0.718 | |
| Modafinil | 3 (7.5%) | 44(48.4%) | <0.001 | |
| Paullinia Cupana/Guarana# | 1 (2.5%) | 3 (3.3%) | 0.955 | |
*p values for Chi-square test (or #Fisher’s exact when necessary) to compare the gender-based differences in characteristics of CE use in CE users only. Percentages are reported as fraction of the total number of male/female in the CEs users.